172@29@16@114!~!172@29@0@53!~!|stocks|stock_market|corp_notices.php?autono=21291081!~!www|moneycontrol|com!~!|stocks|stock_market|corp_notices.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Themis Medicare
Themis Medicare
BSE: 530199NSE: THEMISMEDISIN: INE083B01016

30th-Jul-2020 17:18Source: BSE

Themis Medicare - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Impact Of COVID-19

In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby submit disclosure of impact of COVID-19 Pandemic on the operations and on business of the Company. The Detailed impact of COVID-19 Pandemic in terms of SEBI circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 is enclosed below.

This is for your information and record.

Sections